A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing
Abstract As both 3,4-methylenedioxymethamphetamine (MDMA)- and psilocybin-assisted psychedelic psychotherapy near U.S. Food and Drug Administration (FDA) approval and gain acceptance as efficacious clinical approaches, concerns